marketcompr

Marketcompr is a full-service PR & marketing communications firm. We communicate our clients’ value to clearly defined audiences in credible, sustainable ways.

[Trevi Therapeutics @TreviThera]

Trevi Therapeutics is excited to present at the ATS 2026 International Conference!  

Explore our presentations and connect with our team to learn more about our clinical development in chronic cough. 

PR: https://t.co/Las0NairtJ

#ChronicCough #ATS2026 @atscommunity

[marketcompr @marketcompr]

@CWBChicago Praying for her family. May she rest in peace.

[marketcompr @marketcompr]

Why Pharma products win or lose years before launch https://t.co/6q7ZXjdZPz via @YouTube @TreviThera

[marketcompr @marketcompr]

Er-Kim Leads Pharma & Cosmetics Sector; Places #6 Overall in Bulgaria’s Premier Business Ranking https://t.co/YNitq9QRFR via @ein_news

[marketcompr @marketcompr]

Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference https://t.co/cnGAIfV4F2

[Trevi Therapeutics @TreviThera]

Advancing research in chronic cough treatment.

Take a closer look at the data including the commonly observed adverse events in our topline results presentation at CHEST 2025: https://t.co/9Frd4OMJdd

#ClinicalTrialResults #ChronicCough
#IdiopathicPulmonaryFibrosis

[Trevi Therapeutics @TreviThera]

Trevi is pleased to announce the publication of data from the Phase 2b IPF chronic cough trial of nalbuphine ER in the Journal of the American Medical Association (JAMA).

Read the press release and access the publication here: https://t.co/lke7ur8NIH

@drphilmol @JAMA_current

[Trevi Therapeutics @TreviThera]

Laughing is a frequently reported trigger of chronic cough in patients with idiopathic pulmonary fibrosis.

This patient’s story illustrates how a joyful moment of laughter with friends can quickly trigger a distressing coughing fit.

#VoicesOfChronicCough

[Trevi Therapeutics @TreviThera]

Trevi is excited for the week ahead at the Annual LifeSci Partners Corporate Access Event during the J.P. Morgan Healthcare Conference.

Our senior leadership team looks forward to connecting with global investors and fellow innovators shaping the future of healthcare.

[Trevi Therapeutics @TreviThera]

An exciting start to the new year!

Explore our latest company highlights ahead of the Annual LifeSci Partners Corporate Access Event at the J.P. Morgan Healthcare Conference.

Read the full press release here: https://t.co/PpBGf4uzIo

#ControllingCoughWhereItCounts

[Trevi Therapeutics @TreviThera]

As we wrap up 2025, Jennifer Good, President and CEO, reflects on the meaningful progress made in the past year, and looks ahead to what’s next in 2026.

#ControllingCoughWhereItCounts
#ChronicCough

[Citius Pharma @CitiusPharma]

Our oncology subsidiary, Citius Oncology, expands LYMPHIR™ distribution to Turkey and Middle East countries through an exclusive agreement with Er-Kim, representing a significant milestone in the company’s global expansion strategy.

LYMPHIR international availability extends to 19 markets outside the U.S.

Read the press release: https://t.co/hAwf0Mc7yt $CTOR $CTXR #MarketExpansion #CTCL #Immunotherapy #Oncology

[Trevi Therapeutics @TreviThera]

Trevi announces the appointment of David Hastings as Chief Financial Officer.

With an accomplished career in financial leadership across the life sciences and biopharmaceutical industries, David brings extensive expertise to the Trevi Team.

PR: https://t.co/mhTfM47cOD

[Hartford Business @HartfordBiz]

New Haven clinical-stage drug developer Trevi Therapeutics Inc. announced that David Hastings has been hired as its new chief financial officer, effective Jan. 6, 2026.

https://t.co/Tb8fFkDj3o

[Trevi Therapeutics @TreviThera]

Patient-reported outcomes, meaningful improvement.

For a deeper dive into the data including the commonly observed adverse events, read the topline results presentation from CHEST 2025: https://t.co/ofrnczA3j2

#ChronicCough #IdiopathicPulmonaryFibrosis

[Trevi Therapeutics @TreviThera]

We are excited to share that senior leadership is participating in @Stifel Healthcare Conference.

Trevi’s fireside chat will take place on November 11th at 3:20 p.m. ET for in-person conference attendees.

Press Release: https://t.co/qrXFS7nzm4

#ChronicCough

[marketcompr @marketcompr]

https://t.co/HP1IjQOw1v

[Trevi Therapeutics @TreviThera]

Trevi is proud to share Associate Professor Imran Satia's interview discussing our Phase 2a RIVER trial of nalbuphine ER in patients with refractory chronic cough.

Watch the full interview here: https://t.co/bOpWXLGK9n

#ControllingCoughWhereItCounts
#RefractoryChronicCough

[Trevi Therapeutics @TreviThera]

Backed by positive clinical results, our investigational therapy Haduvio has the potential to redefine what is possible in chronic cough treatment.

#ControllingCoughWhereItCounts

[Acrow Bridge @AcrowBridge]

Bridging Highways UK! Join us at NEC Birmingham for Highways UK 2025, Stand J54!
Discover our modular steel bridging solutions for rapid access and reliable crossings for contractors, engineers, and government agencies.
If you can't attend, contact here: https://t.co/jHPuMXdAD0